Alcon, a renowned eye care product company, in its capacity as borrower and guarantor entered into a USD 1.32 bn revolving credit facilities agreement with, among others, Citibank, London Branch, BNP PARIBAS (SUISSE), Bank of America
Tags :Frank Gerhard
DKSH Holding, a renowned market expansion services provider and trusted partner for companies looking to grow in Asia and beyond, announced the conversion of its existing CHF 150 million revolving credit loan into a sustainability-linked revolving
Evolva Holding announced that it had entered into a new agreement with Nice & Green (N&G) to replace an existing an equity-linked debt instrument issued by Evolva consisting of convertible notes issued in
The Voigt Group and PHOENIX Pharma Switzerland have decided to bring their subsidiaries Voigt and Voigt Industrie Service and Amedis-UE respectively into a 50/50 joint venture. After receiving clearance from the Swiss Competition Commission, this closing
Homburger advised allosteric modulation company Addex Therapeutics in Plan-les-Ouates, Geneva (SIX: ADXN) in the completion of an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares
The controlling shareholder of Reuge, the renowned music box producer, successfully completed the sale of a majority stake in the Reuge manufacture to the Swiss luxury watchmaker De Bethune. The independent watchmaker, known for its
Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
DKSH Holding will sell its 25% stake in Swiss luxury watchmaker Bovet to Pascal Raffy which makes him the watchmaker’s sole owner due that he owns already the 75% of Bovet Fleurier. Raffy, a former pharmaceutical
LatticeFLow, an ETH spin-off pioneering in robust artificial intelligence (AI) having built a system that can automatically find and fix AI data and model errors, announced a USD 12 m Series A funding round led by
PHOENIX Pharma Switzerland, a subsidiary of the family-owned PHOENIX group, and Voigt Holding announced that they agreed to establish a 50/50-joint venture to combine their pharmaceutical distribution services and pre-wholesale activities. The closing of the
